Figure - available from: Frontiers in Physiology
This content is subject to copyright.
Investigation of hereditary spherocytosis red blood cell shapes. Three patients diagnosed with hereditary spherocytosis caused by different mutations (panels A–C) showed a spherocyte count of 11% (A), 8% (B), and 10% (C) in their stained peripheral blood smears, as exemplified in panel A (arrows, objective-magnification 100x). Comparison with 3D-rendered confocal recordings (objective-magnification 60x) of glutaraldehyde fixed and CellMask stained cells, however, demonstrated a different percentage of “true spherocytes”: 2.5% (A), 0% (B), and 0.08% (C). They are visualized in the dark colored boxes, each showing one cell from three perpendicular directions and mostly reflecting the amount observed in healthy subjects (0–0.3%, examined in 15 donors). In contrast, many cells look like spherocytes from one direction (leftmost view in all boxes) but the other faces reveal different morphologies, such as mushroom-shaped cells, stomatocytes or other irregular-shaped cells (all light colored boxes) representing “pseudo spherocytes.” These observations could be confirmed in 10 hereditary spherocytosis patients after 3D-imaging of about 1,000 cells per subject. This Figure is a reprint of Simionato et al. (2021).

Investigation of hereditary spherocytosis red blood cell shapes. Three patients diagnosed with hereditary spherocytosis caused by different mutations (panels A–C) showed a spherocyte count of 11% (A), 8% (B), and 10% (C) in their stained peripheral blood smears, as exemplified in panel A (arrows, objective-magnification 100x). Comparison with 3D-rendered confocal recordings (objective-magnification 60x) of glutaraldehyde fixed and CellMask stained cells, however, demonstrated a different percentage of “true spherocytes”: 2.5% (A), 0% (B), and 0.08% (C). They are visualized in the dark colored boxes, each showing one cell from three perpendicular directions and mostly reflecting the amount observed in healthy subjects (0–0.3%, examined in 15 donors). In contrast, many cells look like spherocytes from one direction (leftmost view in all boxes) but the other faces reveal different morphologies, such as mushroom-shaped cells, stomatocytes or other irregular-shaped cells (all light colored boxes) representing “pseudo spherocytes.” These observations could be confirmed in 10 hereditary spherocytosis patients after 3D-imaging of about 1,000 cells per subject. This Figure is a reprint of Simionato et al. (2021).

Similar publications

Article
Full-text available
We investigated by targeted next generation sequencing the genetic bases of hereditary spherocytosis in 25 patients and compared the molecular results with the biochemical lesion of RBC membrane obtained by SDS-PAGE analysis. The HS diagnosis was based on available guidelines for diagnosis of congenital hemolytic anemia, and patients were selected...
Article
Full-text available
Background: Eosin-5-Maleimide (EMA)-based flow cytometry binds to red blood cell (RBC) membrane-associated proteins which can be used to detect red blood cell (RBC) membrane disorders. Myelodysplastic syndromes (MDS) are stem cell disorders resulting in ineffective hematopoiesis which is commonly present with anemia and erythroid dysplasia. Objec...

Citations

... The latter can be exploited in 3D fluorescence microscopy in stasis [57] and flow [58]. As a result, many RBC-related diseases have derived their names from the shape of the RBCs [59] ranging from sickle cell disease [60] to neuroacanthocytosis syndrome [61]. Furthermore, it is known from rheological and ektacytometric cell population measurements that a crucial parameter (also influenced by RBC storage time) is RBC deformability. ...
Article
Full-text available
Background: "Artificial intelligence" and "big data" increasingly take the step from just being interesting concepts to being relevant or even part of our lives. This general statement holds also true for transfusion medicine. Besides all advancements in transfusion medicine, there is not yet an established red blood cell quality measure, which is generally applied. Summary: We highlight the usefulness of big data in transfusion medicine. Furthermore, we emphasize in the example of quality control of red blood cell units the application of artificial intelligence. Key messages: A variety of concepts making use of big data and artificial intelligence are readily available but still await to be implemented into any clinical routine. For the quality control of red blood cell units, clinical validation is still required.